Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01356277 · ClinicalTrials.gov registry record · NA

Intervention to Improve Adherence in Teen Kidney Transplant

A NA study of Medication Adherence and Kidney Transplantation, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

Completed
Registry status
NA
Development phase
170
Enrollment target
8
Study locations

NCT01356277: Completed NA study of Medication Adherence and Kidney Transplantation, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

NCT01356277 is a NA study of Medication Adherence and Kidney Transplantation that has completed, run by McGill University Health Centre/Research Institute of the McGill University Health Centre. The registered enrollment target is 170 participants, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01356277, a NA study of Medication Adherence and Kidney Transplantation, has completed, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

COMPLETED
Registry status
NA
Development phase
170 participants
Enrollment target
8
Study locations

Study Summary

The broad aim of the proposed study is to improve medication adherence in adolescent kidney transplant recipients. The investigators hypothesize that a multi-component intervention will improve medication adherence in the adolescent kidney transplant population. The specific aims are to determine, in a randomized clinical trial, the efficacy of a structured, multi-component intervention in improving adherence to anti-rejection medications and graft outcomes, and to identify characteristics of healthcare systems that are independently associated with adherence.

Primary Outcome

Daily "taking adherence", defined as the percentage of prescribed doses taken each day (as measured by electronic monitoring). The daily taking adherence score could take a value of 0%, 50%, or 100% for patients on twice daily dosing, and 0% or 100% for patients on once daily dosing. Each patient had a taking adherence score for every day of observation (repeated measures). On days that the pillbox was not in use due to technical problems or participant non-use (due to travel etc), no score was

Conditions Studied

Medication Adherence Kidney Transplantation

Interventions

  • BEHAVIORAL Action-focused problem-solving
  • DEVICE Electronic pillbox monitoring, dose reminders, and feedback

Study Locations (8)

Quebec

  • Montreal Children's Hospital - Montreal
  • St. Justine's Hospital - Montreal

Missouri

  • Washington University School of Medicine - St Louis

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Washington

  • Seattle Children's Hospital - Seattle

British Columbia

  • British Columbia Children's Hospital - Vancouver

Ontario

  • University of Toronto Hospital for Sick Children - Toronto

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2012-02
Est. Completion 2016-06
Phase NA
McGill University Health Centre/Research Institute of the McGill University Health Centre

9 total trials

What the finished NCT01356277 record still lists

NCT01356277 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,654-participant average among 52 other Medication Adherence trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 2 interventions - of which Action-focused problem-solving is the first listed.

NCT01356277 lists 8 locations in 7 states (Quebec, Missouri, Ohio).

Frequently Asked Questions

What is clinical trial NCT01356277 about?

NCT01356277 is a clinical study titled "Intervention to Improve Adherence in Teen Kidney Transplant". The broad aim of the proposed study is to improve medication adherence in adolescent kidney transplant recipients. The investigators hypothesize that a multi-component intervention will improve medication adherence in the adolescent kidney transplant population. The specific aims are to determine, i...

What is the current status of trial NCT01356277?

This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2012-02. Estimated completion is 2016-06.

What conditions does trial NCT01356277 study?

This clinical trial studies the following conditions: Medication Adherence, Kidney Transplantation.

What interventions are being tested in trial NCT01356277?

The interventions under investigation include: Action-focused problem-solving (BEHAVIORAL), Electronic pillbox monitoring, dose reminders, and feedback (DEVICE).

Who is sponsoring clinical trial NCT01356277?

This trial is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01356277 being conducted?

This trial has 8 study locations across Missouri, Ohio, Pennsylvania, Washington, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01356277's enrollment target sits among peer trials

170 24th of 52 higher than 29 of 52 other Medication Adherence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01356277, the US trial registry maintained by the National Library of Medicine. NCT01356277 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.